September 28, 2016 6:27 AM ET


Company Overview of Mersana Therapeutics, Inc.

Company Overview

Mersana Therapeutics, Inc. is a biotechnology company that discovers, engineers, and develops antibody drug conjugates to cure various cancers. The company develops immune conjugate therapies to create drugs that enhance patients’ lives. It offers XMT-1522, a drug therapy for tumor models that express relatively low amounts of the HER2 protein; and human anti-HER2 antibody used in XMT-1522. Mersana Therapeutics, Inc. has strategic alliances with Takeda Pharmaceutical Company Limited; Merck Serono; and Asana BioSciences. The company was formerly known as Nanopharma Corp. and changed its name to Mersana Therapeutics, Inc. in November 2005. Mersana Therapeutics, Inc. was founded in 2001 and is ...

840 Memorial Drive

Cambridge, MA 02139

United States

Founded in 2001





Key Executives for Mersana Therapeutics, Inc.

Chief Executive Officer, President and Director
Age: 52
Executive Chairman
Age: 51
Vice President of Finance
Chief Medical Officer
Compensation as of Fiscal Year 2016.

Mersana Therapeutics, Inc. Key Developments

Mersana Therapeutics Appoints Kristen Hege, M.D., to Board of Directors

Mersana Therapeutics, Inc. announced the appointment of Kristen M. Hege, M.D., to its board of directors. Since 2010, Dr. Hege has served as Celgene Corporation’s medical lead for Translational Development, currently as a Corporate Vice President, where she is responsible for early phase development of the company’s significant oncology and hematology pipeline.

Mersana Therapeutics, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016

Mersana Therapeutics, Inc. Presents at The 23rd Annual NewsMakers in the Biotech Industry Conference, Sep-09-2016. Venue: Millennium Broadway Hotel & Conference Center, New York, New York, United States. Presentation Date(s): Sep-09-2016.

Mersana Therapeutics, Inc. Presents at 2016 Credit Suisse Antibody Day, Sep-07-2016 12:40 PM

Mersana Therapeutics, Inc. Presents at 2016 Credit Suisse Antibody Day, Sep-07-2016 12:40 PM. Venue: Credit Suisse Offices, One Madison Avenue at 24th Street, 12th Floor, New York, New York, United States. Speakers: Timothy B. Lowinger, Chief Scientific Officer.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

Private Placement
June 15, 2016

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
The Advertising Council, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Mersana Therapeutics, Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at